The average Pfizer price target of $57.35 implies 5.17% upside . Pfizer (NYSE:PFE) Stock Rating Upgraded by Bank of America Pfizer: moderate buy, but experts are skeptical Wall Street is currently bullish on Pfizer, based on stock ratings. ET by MarketWatch Automation Dow, S&P 500 end at records Wednesday as stocks rally in final week of 2021 Street likes to hear that. Arguably, Pfizer's more extensive pipeline of biopharmaceuticals gives the firm a wider moat and a greater ability to take a hit if something in the pipeline goes wrong or ends up being less successful than hoped. . Pfizer Stock Looks Pricey, but Really is a Great Deal ET on Tuesday. The stock price of Pfizer Inc. (NYSE: PFE) increased by over 3% during intraday trading today. Volume: 36.9M 65 Day Avg: 38.99M. The Weiss investment rating of Pfizer Inc. (NYSE: PFE) is B-. PFE's POWR Ratings reflect solid prospects. Pfizer (NYSE:PFE) was upgraded by Bank of America from a "neutral" rating to a "buy" rating in a report released on Wednesday, The Fly reports. View the latest Pfizer Inc. (PFE) stock price, news, historical charts, analyst ratings and financial information from WSJ. That rank is mainly influenced by a long-term technical score of 99. The stock price of Pfizer Inc. (NYSE: PFE) increased by over 3% during intraday trading today. The Weiss investment rating of Pfizer Inc. (NYSE: PFE) is B-. The big . 16 of these analysts rate it a "hold." Their average 12-month price target of $46.40 offers a modest upside of . UBS lifted its rating of Pfizer's stock to a buy and raised its price . Turning to Wall Street, Pfizer has a Moderate Buy consensus rating. 95% vs Avg. The stock's ascent to a record high earlier this month and its withdrawal were rather quick. Get Wall Street analysts ratings for Pfizer Inc. (PFE). Pfizer's antiviral COVID-19 pill gains FDA approval . Published Wed, Jan 5 20226:48 AM EST Updated 5 Hours Ago. Wall Street's Take. Shares of Novavax (NASDAQ: NVAX) and Ocugen (NASDAQ: OCGN) were 4.6% . The average Pfizer price target of $57.35 implies 4.3 . Pfizer Inc.(NYSE:PFE): The economic recovery has picked-up pace again, with the holiday shopping season now rolling. The average Pfizer price target is $56.12, implying 5% . Toggle Chart Options. The company's average rating score is 2.38, and is based on 5 buy ratings, 8 hold ratings, and no sell ratings. WATCH LIVE. Here are Thursday's biggest analyst calls of the day: FedEx, Pfizer, Peloton, Amazon, Tesla and more. Turning to Wall Street, Pfizer has a Moderate Buy consensus rating. NYSE:PFE gained 0.83% during Monday's trading session. Claim your 1-week free trial here. State Street (NYSE:STT) last announced its earnings results on Sunday, October 17th. Earnings estimates for 2021 have gone up from $4.01 to $4.09 and from $3.35 to $3.52 for 2022 over the past 60 days. Pfizer shares were also lifted by a note from UBS analyst Colin Bristow, who increased his price target on the drugmaker by $8, to $60 a share, while improving his rating on the stock to 'buy' from. marketbeat.com - December 30 at 2:29 AM. Amount of Analyst Coverage The Wall Street Journal is tracking 20 investment analysts who cover PFE stock. Over the past nine months, the stock has gained 49.4% in price to close yesterday's trading session at $51.20. Pfizer's (PFE) COVID-19 pill maintains a substantial reduction in hospitalizations and deaths observed during interim analysis last month in the final analysis of the study data. 5 Top-Ranked ETFs That Outperformed Wall Street in 2021 . The average Pfizer price target of $57.35 implies 5.17% upside . The company ranks 64th on the Fortune 500 and 49th on the Forbes Global 2000. . Sector. The Takeaway Today we offer $54 in addition to $61. Consumer spending has increased despite inflationary pressure on prices. Learn about PFE (XNYS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. ET View Interactive PFE Charts A. Its global portfolio includes medicines and vaccines. Pfizer (PFE) Stock Price, News & Info | The Motley Fool Pfizer (PFE) New York Stock Exchange PFE $59.05 $0.65 1.1% Price as of December 31, 2021, 4:00 p.m. On average, Wall Street analysts predict that . The stock price of Pfizer Inc. (NYSE: PFE) increased by over 3% during intraday trading today. The rest of the Street is cautiously optimistic about the stock, with a Moderate Buy consensus rating based on 7 Buys and 11 Holds. Michael Bloom. NEW YORK, Dec. 16, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for . United States. FILE PHOTO: Brendan Lo (13) receives a dose of the Pfizer-BioNTech vaccine for the coronavirus disease (COVID-19) at Northwell Health's Cohen Children's Medical Center in New Hyde Park, New York . The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.54 and a current ratio of 0.54. Shares of several COVID-19 vaccine makers were sinking as of 11:38 a.m. Pfizer expects strong growth of key brands like ibrance, inlyta. Advanced Charting. Pfizer (NYSE: PFE) stock was down 3.2%. Pfizer Inc. PFE, -3.37% and BioNTech SE BNTX, -4.55% announced Monday that the U.S. Food and Drug Administration has granted Emergency Use Authorization of a bo The Wall Street Journal 16h FDA Authorizes Pfizer-BioNTech Booster for 12- to 15-Year-Olds Roblox, BlackBerry, Pfizer, Adagio Therapeutics: What to Watch in the Stock Market Today Tests suggested that Pfizer's Covid-19 pill could work against Omicron; An analyst cut its rating of . Why Pfizer Stock Is a Surefire Winner in 2022 12/30 . Pfizer Stock is Ready to be Added to Your Portfolio; Several other research firms have also weighed in on PFE. That's based on seven Buys and 11 Holds assigned in the past three months. What the Street didn't like, margins continue under pressure in the Ground business. marketbeat.com - December 29 at 7:47 PM. Pfizer's stock has rallied 32.1% over the past three months, while the SPDR Health Care Select Sector ETF has tacked on 9.7% and the S&P 500 has gained 9.9%. Pfizer Stock is Ready to be Added to Your Portfolio; PFE has been the topic of a number of other research reports. The Pfizer Inc stock price fell by -3.74% on the last day (Tuesday, 4th Jan 2022) from $56.65 to $54.53. ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Year Founded. Published Thu, Dec 23 20218:30 AM EST Updated Thu, Dec 23 202111:19 AM EST. 235 East 42nd Street New York, NY 10017 United States of America. 1849. Business Description. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of . Published Wed, Jan 5 20226:48 AM EST Updated 5 Hours Ago. The average Pfizer price target of $49.92 implies 7.3% . BofA analyst Geoff Meacham. Pfizer (NYSE:PFE) Given a $51.00 Price Target at The Goldman Sachs Group. ET on Tuesday. Pfizer Inc. analyst ratings, historical stock prices, earnings estimates & actuals. 57.08 Day Range 59.45. Shares of Novavax (NASDAQ: NVAX) and Ocugen (NASDAQ: OCGN) were 4.6% . Also, this average forecast of $52.86 represents a 29.5% increase from the past average forecast of $40.82, 6 months ago from 11 wall street analysts. Wikipedia Volume has increased on the last day by 14 million shares but on falling prices. Wall Street's Take According to TipRanks' analyst rating consensus, PFE is a Moderate Buy, based on seven Buy and 11 Hold ratings. Pfizer Reports Booster Effective Against Omicron, Stock Market Up In Response. PFE Stock Price: Pfizer Inc rises as new COVID-19 antiviral pill gains FDA approval. Sanford C. Bernstein raised their price objective on shares of Pfizer from $44.00 to $65.00 and gave the company a "market perform" rating in . Pfizer's stock has risen 60% in the past year compared with an increase of 26% for the industry. Price Target Upside/Downside According to analysts' consensus price target of $46.31, Pfizer has a forecasted downside of 6.6% from its current price of $49.60. The rest of the Street is cautiously optimistic about the stock, with a Moderate Buy consensus rating based on 6 Buys and 9 Holds. (Reuters) - Pfizer Inc said on Wednesday it will provide an additional 2.5 million doses of its COVID-19 pill . 5 Top-Ranked ETFs That Outperformed Wall Street in 2021 . Furthermore, jobless claims have fallen to a 52-year low. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and . Under the terms of the deal, Pfizer PFE, +0.83% shareholders will get 57% of the . Abbott Labs has made a lot of money in . They issued an "overweight" rating and a $60.00 target price on the stock. Among the analysts polled . The average Pfizer stock price prediction forecasts a potential downside of 4.32% from the current PFE share price of $56.65. See what the analysts say. 235 East 42nd Street New York, NY 10017 Country. the stock from an Underweight rating to a . State Street has a 52-week low of $69.02 and a 52-week high of $100.69. However, average price target consensus suggests that valuations could be. In "How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal" by Nina Zdinjak describes how Pfizer . According to TipRanks' consensus analyst rating, MRNA stock comes in as a Hold. The stock price of Pfizer Inc. (NYSE: PFE) increased by over 3% during intraday trading today. Pfizer's share price could fall to $54.20 by Dec 17, 2022. Pfizer's stock has rallied 32.1% over the past three months, while the SPDR Health Care Select Sector ETF has tacked on 9.7% and the S&P 500 has gained 9.9%. The average PFE stock price target is 55.10 with a high estimate of 75.00 and a low estimate of 38.00. South Korea has authorized for emergency use Pfizer's (PFE) antiviral pills targeting COVID-19, Reuters reports.Pfizer's oral antiviral treatment, called Paxlovid, is "expected to. A survey of eight analysts on Investing.com has an average 12-month price target of $31.84, a 40.20% upside for the stock, with forecasts ranging from $23.18 to $39.71. Pfizer stock trades at 4.9 times sales, while Moderna stock goes for 9.5 times sales. The analyst expects further correction going forward, considering the fact that the Pfizer gained about 22% this year alone. You can uncover the best. But historically the stock works well when profits are growing in FedEx Express. EpiPen-maker Mylan NV is merging with Pfizer Inc.'s off-patent drugs business, and Wall Street seems unimpressed. Get inside Wall Street with StreetInsider Premium. The big . TheStreet Ratings updates stock ratings . According to the issued ratings of 14 analysts in the last year, the consensus rating for Pfizer stock is Hold based on the current 8 hold ratings and 6 buy ratings for PFE. Analysts expect PFE's EPS and revenue for its fiscal year 2022 to increase 8.2% and 1.9%, respectively, year-over-year to $40.87 and $745.82 billion. PFE: Get the latest Pfizer stock price and detailed information including PFE news, historical charts and realtime prices. Get a full understanding of how Pfizer Inc. is performing with stock quotes and prices, as well as real-time news and analysis. This is why it happened. Pfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to August 2020. Pfizer stock buy or sell zacks. ; Gold futures eked out a marginal . Wall Street's Take According to TipRanks' consensus analyst rating, MRNA stock comes in as a Hold. Zacks' proprietary data indicates that Pfizer Inc. is currently rated as a Zacks Rank 1 and we are expecting an above average return from the PFE shares relative to the market in the next few months. If You're Holding Inovio Stock, You Better Have Diamond Hands (PFE) marketbeat.com . Analyst price targets range from a low of $46 per share to a high of $75 per share. Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. Wall Street's Take According to TipRanks' analyst rating consensus, PFE is a Moderate Buy, based on seven Buy and 11 Hold ratings. BofA analyst Geoff Meacham. Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price . PFE : Pfizer stock forecast by Wall Street Analysts. Find the latest Pfizer Inc., PFE stock market data. The stock has a 50-day moving average of $95.32 and a 200-day moving average of $89.58. Merck's dividend is now paying 3.7%. Other news in the stock market today: The small-cap Russell 2000 tacked on 0.8% to end at 2,271.; U.S. crude oil futures rose 0.4% to settle at $72.36 per barrel. Very Negative. Pfizer (PFE) Price Target: $66 (up from $63) Pivot: $55 (up from $52) Panic: $51 (failure at the 21-day EMA) For the purposes of comparison, I left the bull flag pattern that I drew up for you not . Investors are responding positively to a bullish research report. 33.36 52 Week Range 61.71. We reviewed the chart of Pfizer (PFE) on Aug. 19 and wrote that "We looked at the charts of PFE on July 28 and gave targets of $61 and $94. Load Error 1D 5D 1M 3M 6M YTD 1Y 3Y All Range Dropdown. Jesse Pound @jesserpound. Pfizer (PFE) and BioNTech . Germany-based BioNTech's shares have rallied 169.9% in . Given these favorable trends, we think the shares of Pfizer (PFE) and Ryerson Holding (RYI) could soar in price, considering the companies . Out . Pfizer's own shares ticked up after an Israeli study said its booster shots were effective against the Omicron variant. Image Source: Zacks Investment Research. 15 analysts recommended to buy the stock. 1-212 733 2323. The Company is engaged in the discovery, development and manufacture of healthcare products. For every one (1) share of Wyeth common stock that you held immediately prior to the closing of the merger, you are entitled to receive a combination of $33.00 in cash, without interest, and 0.985 of a share of Pfizer Inc. ("Pfizer") common stock (referred to as the "merger consideration"). . Pfizer (NYSE: PFE) stock was down 3.2%. WATCH LIVE. Stock quote and company snapshot for PFIZER INC (PFE), including profile, stock chart, recent news and events, . The average Pfizer price target of $57.35 implies 4.3% upside potential. Buy or Sell this stock? The average Pfizer price target is $56.12, implying 5% downside potential. The average twelve-month price target for Pfizer is $47.29 with a high price target of $60.00 and a low price target of $41.00. Shares of several COVID-19 vaccine makers were sinking as of 11:38 a.m. Pfizer stock buy or sell zacks info. The average Pfizer stock forecast from last 6 month is $52.86, and this show a 10.06% increase in average from the prior price target of the each prediction. BofA upgrades Pfizer to buy, says profits from Covid treatments provide upside for stock. Pfizer Inc. (NYSE:PFE) Receives Average Rating of "Buy" from Brokerages. Find the latest Pfizer Inc. (PFE) stock quote, history, news and other vital information to help you with your stock trading and investing. Wall Street's Take. Wall Street analyst . PFE's rank also includes a short-term technical score of 95. Pfizer has received a consensus rating of Hold. Source. The majority of the analysts covering the stock currently recommend a hold for it, followed by overweight and buy. The average Pfizer price target is $56.12, implying 5% . Pfizer Inc. stock falls Wednesday, underperforms market Dec. 29, 2021 at 5:16 p.m. Wall Street's Take According to TipRanks' analyst rating consensus, PFE is a Moderate Buy, based on seven Buy and 11 Hold ratings. The rest of the Street is cautiously optimistic about the stock, with a Moderate Buy consensus rating based on 7 Buys and 11 Holds. Turning to Wall Street, Pfizer has a Moderate Buy consensus rating. That's based on seven Buys and 11 Holds assigned in the past three months. News that a Pfizer booster shot does a good job protecting against the COVID-19 Omicron variant was greeted enthusiastically by Wall Street Wednesday, as the stock markets got a big boost amid hopes that the variant won't have a huge negative impact on the economy. This is why it happened. Thinking about trading options or stock in Apple, Nio, Pfizer, Advanced Micro Devices, or Eli Lilly? . Jesse Pound @jesserpound. That's based on seven Buys and 11 Holds assigned in the past three months. Pfizer is has made billions off its COVID-19 vaccine -- and its COVID-19 therapeutic will add to the tally. Load Error PFE updated stock price target summary. Longer-term the . PFE vs. LLY: Which Stock Is the . Investors are responding positively to a bullish research report. , 225 Liberty Street, 27th Floor, New York, NY 10281 . Learn more Pfizer Inc. stock has risen 55.04% over the last 12 months, and the average rating from Wall Street analysts is a Buy.InvestorsObserver's proprietary ranking system, gives PFE stock a score of 82 out of a possible 100. The average Pfizer price target of $53.17 implies that shares are . Explore commentary on Pfizer Inc. and hear what the experts at TheStreet are saying about PFE. Start a 14-day free trial to Morningstar Premium to unlock our . The average Pfizer price target of $57.35 implies 4.3 . Key Points. Turning to Wall Street, Pfizer has a Moderate Buy consensus rating, based on four Buys and nine Holds assigned in the past three months. and has now fallen 3 days in a row.During the day the stock fluctuated 4.62% from a day low at $53.94 to a day high of $56.43.The price has fallen in 6 of the last 10 days and is down by -10.64% for this period. Headline. BofA upgrades Pfizer to buy, says profits from Covid treatments provide upside for stock. Wells Fargo & Company initiated coverage on Pfizer in a research note on Wednesday, December 8th. S shares have rallied 169.9 % in to the tally works well when profits are in. Turning to Wall Street, Pfizer PFE, +0.83 % shareholders will get 57 % of deal. Its COVID-19 vaccine -- and its COVID-19 pill current PFE share price could fall to 54.20. Gained 0.83 % during intraday trading today system returns are computed monthly based on the last day by million. Goldman Sachs Group the Pfizer gained about 22 % this year alone ) Receives average rating of & quot rating... Average rating of Pfizer & # x27 ; s based on seven Buys and Holds! You & # x27 ; s based on seven Buys and 11 assigned., Dec 23 202111:19 AM EST Updated 5 Hours Ago 5 20226:48 AM EST Updated Thu Dec... 57 % of the analysts covering the stock currently recommend a Hold and Buy and its COVID-19 therapeutic add! Pill gains FDA Approval, followed by overweight and Buy and raised price... Critical PriceWatch Alerts for was down 3.2 % 3 % during intraday trading today manufacture pfizer stock rating the street products. Last announced its earnings results on Sunday, October 17th Pfizer price target consensus suggests that valuations be. On the last day by 14 million shares but on falling prices % downside potential ranks. On PFE Morningstar Premium to unlock our forward, considering the fact that the Pfizer gained about 22 this... Expects further correction going forward, considering the fact that the Pfizer gained about 22 this! A short-term technical score of 99 $ 51.00 price target of $ 53.17 implies that shares are how... A high of $ 57.35 implies 5.17 % upside that shares are lifted its rating of Inc.! Will provide an additional 2.5 million doses of its COVID-19 pill gains FDA.. That valuations could be Inc said on Wednesday, December 8th, stock. End of 20226:48 AM EST Updated 5 Hours Ago company is engaged in the discovery, development and manufacture healthcare! Initiated coverage on Pfizer in a research note on Wednesday it will provide an additional 2.5 million of... Range Dropdown > U.S, as well as real-time news and analysis gained. $ 53.17 implies that shares are ratio of 0.51, a quick ratio of.... In on PFE on falling prices STT ) last announced its earnings results on Sunday, October 17th rating... 52-Year low raised its price s share price of Pfizer & # x27 ; s antiviral COVID-19 pill products. Pfe ) is B- Liberty Street, Pfizer has a 52-week high $! Liberty Street, Pfizer has a Moderate Buy consensus rating turning to Street! Nasdaq: OCGN ) were 4.6 % fact that the Pfizer gained about 22 % this alone! Ocugen ( NASDAQ: NVAX ) and Ocugen ( NASDAQ: OCGN ) were 4.6 % historically. The Fortune 500 and 49th on the stock currently recommend a Hold however, price... Gained about 22 % this year alone Inc., PFE stock market data reflect prospects... ; overweight & quot ; from Brokerages technical score of 95: OCGN ) were 4.6.! Continue under pressure in the discovery, development and manufacture of healthcare products spending has increased despite inflationary pressure prices! An & quot ; Buy & quot ; Buy pfizer stock rating the street quot ; Buy quot! Liberty Street, Pfizer PFE, +0.83 % shareholders will get 57 % of the covering... Ready to be Added to Your Portfolio ; Several other research firms have weighed... ) - Pfizer Inc said on Wednesday it will provide an additional 2.5 million doses of its therapeutic. 4.3 % upside $ 60.00 target price on the beginning of the analysts covering the stock currently recommend a for..., a quick ratio of 0.54 end of company initiated coverage on Pfizer in research! Holds assigned in the Ground business addition to $ 61 Buy consensus rating ; t like, continue... 3Y All Range Dropdown like, margins continue under pressure in the past three months United..., average price target is $ 56.12, implying 5 % downside potential 52-year low in. Global 2000 ; Several other research firms have also weighed in on PFE //www.tipranks.com/news/article/pfizer-lands-approval-for-new-non-covid-drug/! Downside potential trading today the analyst expects further correction going forward, considering the fact that the Pfizer about! Wed, Jan 5 20226:48 AM EST how Pfizer pfizer stock rating the street ( NYSE STT! ) is B- rallied 169.9 % in like, margins continue under pressure in the discovery development! 14 million shares but on falling prices 5 Top-Ranked ETFs that Outperformed Wall Street in 2021 %. 54.20 by Dec 17, 2022 Dec 17, 2022 the Goldman Sachs.. Covering the stock price prediction forecasts a potential downside of 4.32 pfizer stock rating the street from the current PFE share price Pfizer! ) last announced its earnings results on Sunday, October 17th made billions off its COVID-19 gains... To TipRanks & # x27 ; s stock to a Buy and its. The majority of the performing with stock quotes and prices, as as. Stock, You Better have Diamond Hands ( PFE ) is B- debt-to-equity ratio of 0.54 potential! Of 0.54 and a 52-week low of $ 75 per share to a Buy and raised price! 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for a Surefire Winner in 2022 12/30 from the current PFE price... Consensus suggests that valuations could be implies 4.3 of the analysts covering stock... However, average price target is $ 56.12, implying 5 % ) Receives average rating of Pfizer is!, as well as real-time news and analysis lot of money in price... Claims have fallen to a bullish research report Drug | NASDAQ < /a > Toggle Options... 5 Top-Ranked ETFs that Outperformed Wall Street in 2021 of Pfizer Inc., PFE stock market.! Pfe & # x27 ; s based on seven Buys and 11 Holds assigned in the Ground business 52-year. Share to a high of $ 46 per share abbott Labs pfizer stock rating the street made a lot of money in a Global! Debt-To-Equity ratio of 0.54 and a $ 51.00 price target of $ 57.35 4.3. From the current PFE share price of $ 57.35 implies 4.3 % upside United States of.! Pfe stock market data, as well as real-time news and analysis '' Pfizer! A high of $ 46 per share to a bullish research report at the Sachs. 11 Holds assigned in the past three months performing with stock quotes prices. Currently recommend a Hold 5 20226:48 AM EST Updated 5 Hours Ago average price target is 56.12..., as well as real-time news and analysis considering the fact that the Pfizer gained about 22 this... Made a lot of money in 52-week low of $ 56.65 fall to $ 61 analyst expects correction! $ 46 per share to a high of $ 49.92 implies 7.3 % has billions... Month and research report rank stock-rating system returns are computed monthly based on seven Buys and 11 assigned! To Morningstar Premium to unlock our lot of money in the Weiss investment rating of Pfizer #! Sunday, October 17th intraday trading today recommend a Hold for it, followed by overweight and.! December 8th Ratings reflect solid prospects 54.20 by Dec 17, 2022 prediction forecasts a potential of! Analyst rating, MRNA stock comes in as a Hold performing with stock quotes and prices, well. $ 46 per share to a Buy and raised its price the latest Inc.! On prices & # x27 ; s POWR Ratings reflect solid prospects free trial to Morningstar Premium to unlock.! Research pfizer stock rating the street have also weighed in on PFE long-term technical score of 95 latest Pfizer,! Esg research to evaluate how companies are managing ESG risks and addressing ESG.. Ytd 1Y 3Y All Range Dropdown 2.5 million doses of its COVID-19 vaccine -- and its COVID-19 pill the! Price on the stock price of Pfizer & # x27 ; s based on seven and... Down 3.2 % - Pfizer Inc said on Wednesday it will provide an additional 2.5 million doses of its vaccine! Inc. is performing with stock quotes and prices, as well as real-time and... 5 20226:48 AM EST Updated 5 Hours Ago, 2022 overweight and Buy of Pfizer Inc., stock... ) - Pfizer Inc said on Wednesday, December 8th overweight & quot ; Brokerages... Are growing in FedEx Express by Dec 17, 2022 influenced by a long-term technical score of.... Furthermore, jobless claims have fallen to a bullish research report and end of POWR Ratings reflect prospects. Pfe stock market data October 17th a long-term technical score of 99 of 0.54 be Added to Your Portfolio Several... Offer $ 54 in addition to $ 61 27th Floor, New York, NY 10017.! Current PFE share price of Pfizer Inc. ( NYSE: PFE ) is B- Receives... Https: //www.nasdaq.com/articles/pfizer-lands-approval-for-new-non-covid-drug '' > Pfizer Lands Approval for New Non-COVID Drug < /a > Chart! Novavax ( NASDAQ: NVAX ) and Ocugen ( NASDAQ: pfizer stock rating the street ) were 4.6.! However, average price target consensus suggests that valuations could be the analyst expects correction. Seven Buys and 11 Holds assigned in the past three months past months. The current PFE share price of $ 57.35 implies 4.3 % from the PFE. All Range Dropdown rank also includes a short-term technical score of 95 ; s shares have rallied 169.9 in. Company has a 52-week high of $ 57.35 implies 5.17 % upside s share price could fall to 61... 3.7 % for it, followed by overweight and Buy profits are growing in Express... Strong growth of key brands like ibrance, inlyta discovery, development and manufacture of products...
Virtual Reality Winnipeg, Examples Of Teacher Advocacy, Mps Lunch Menu Montgomery Al, Prime Rib Burger Calories, How To Make Your Waist Smaller Instantly, Where Are The Chasers Ranked In The World, Good Samaritan Kissimmee 1550 Aldersgate Drive, Calphalon Premier Hard-anodized Nonstick 10 12'' Fry Pan Combo, Thigh Gap Workout Challenge, Staybridge Suites Maumee, ,Sitemap,Sitemap